Home
Silence Therapeutics

Silence Therapeutics Market Share Analysis for November 2025

Silence Therapeutics, is a London-based pharmaceutical company formed in 1994. The company since its inception has pioneered the design and development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases.

Science and Education > Biology

Domainsilence-therapeutics.com

Year Founded1994

Employees51 - 200

Annual Revenue$15M - $25M

Silence Therapeutics

Silence Therapeutics (including company regionals)

silence-therapeutics.com

See more website traffic and engagement information

Silence Therapeutics Revenue up to November 2025 is 15M - 25M

revenue generated by Silence Therapeutics top domains

Silence Therapeutics top domains revenue over 3 years

Revenue for Silence Therapeutics top domains

silence-therapeutics.com15M - 25M

See more with Sales Intelligence

Total visits to Silence Therapeutics's top domains

Understand Silence Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

silence-therapeutics.com8.7K

See more with Sales Intelligence

Avg. visit duration in Silence Therapeutics's top domains

Analyze Silence Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

silence-therapeutics.com00:01:32

See more with Sales Intelligence

Avg. pageviews on Silence Therapeutics's top domains

See how Silence Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

silence-therapeutics.com2.29

See more with Sales Intelligence

Silence Therapeutics top competitors by domain

Top similar sites in November 2025, ranked by their affinity

alnylam.comCompany NameAlnylam Pharmaceuticals, Inc.Employees1001 - 5000HQUnited States, Massachusetts, CambridgeAnnual revenue> $1BTotal visits82.5KScience and Education > Biology

Top technologies used by Silence Therapeutics

These are the website technologies, by industry, used by Silence Therapeutics top domains

Conversion & Analytics (3)

Google Analytics

Audio Video Media (2)

YouTube

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

More Technologies

8

See all

News & Signals from Silence Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSilence Therapeutics plc attended event European Hematology Association (EHA) 2025 Annual Meeting on Jun 13th '25.LONDON, UK I June 12, 2025 I Silence Therapeutics plc ("Silence" or the "Company") (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today presented additional data showcasing the SANRECO Phase 1 study of divesiran in patients with polycythemia vera (PV) at the European Hematology Association (EHA) 2025 Annual Meeting in Milan, Italy.

NewsSilence Therapeutics plc attended event American Heart Association (AHA) conference on Nov 1st '25.When Silence Therapeutics unveiled its latest zerlasiran phase 2 data at the American Heart Association (AHA) conference in November, the British biotech sounded confident that the latest readout set them up for a phase 3 trial.

NewsSilence Therapeutics plc is developing RNA-based drug delivery systems.His past roles include leading financial operations at Juvenescence, a company developing treatments to enhance healthy ageing; Silence Therapeutics, which specialises in therapies based on the body's natural gene-silencing process, RNA interference; and Sixfold Bioscience, which uses artificial intelligence and machine learning to develop RNA-based drug delivery systems.